42 results
6-K
EX-99.2
LMNL
Liminal BioSciences Inc.
8 Aug 23
Liminal BioSciences Reports Second Quarter Financial Results 2023
4:10pm
not use financial instruments for trading purposes and have not issued or acquired derivative financial instruments for hedging purposes. The following
6-K
EX-99.2
LMNL
Liminal BioSciences Inc.
9 May 23
Liminal BioSciences Reports First Quarter Financial Results 2023
4:10pm
instruments for hedging purposes. The following table presents the carrying amounts of our financial instruments at March 31, 2023 and December 31, 2022
6-K
EX-99.1
LMNL
Liminal BioSciences Inc.
15 Dec 22
Notice of Special Meeting of Shareholders
4:03pm
"functional currency" is not the U.S. dollar; (ix) persons holding Common Shares as a position in a hedging transaction, "straddle," "conversion
6-K
EX-99.2
LMNL
Liminal BioSciences Inc.
9 Nov 22
Liminal BioSciences Reports Third Quarter 2022 Financial Results and Business Highlights
4:11pm
for trading purposes and have not issued or acquired derivative financial instruments for hedging purposes. The following table presents the carrying
6-K
EX-99.2
LMNL
Liminal BioSciences Inc.
10 Aug 22
Liminal BioSciences Reports Second Quarter 2022 Financial Results and Business Highlights
12:00am
derivative financial instruments for hedging purposes. The following table presents the carrying amounts of our financial instruments at June 30
6-K
EX-99.2
rgmv36rb077rdp wc3
10 May 22
Liminal BioSciences Reports First Quarter 2022 Financial Results and Business Highlights
4:55pm
6-K
EX-99.2
e1avgp525c ymtwsdkk
16 Nov 21
Liminal BioSciences Reports Third Quarter 2021 Financial Results
12:00am
6-K
EX-99.2
h6wl2 sz1j1speoe
16 Aug 21
Liminal BioSciences Reports Second Quarter 2021 Financial Results
5:08pm
6-K
EX-99.2
yhf7u
17 May 21
Liminal BioSciences Reports First Quarter 2021 Financial Results
5:11pm
424B3
dftmnboalij6i
11 Dec 20
Prospectus supplement
12:00am
424B3
x96zb4xrrq
10 Dec 20
Prospectus supplement
9:53pm
POS AM
acrloera
2 Dec 20
Prospectus update (post-effective amendment)
12:00am
F-3
hcdb8kryt4c
2 Dec 20
Shelf registration (foreign)
12:00am
424B3
87bzqcml4s3y he
12 Nov 20
Prospectus supplement
5:21pm
6-K
EX-99.2
k2zd9wqxqvs7d8rd
12 Nov 20
Liminal BioSciences Reports Third Quarter Financial Results
5:07pm
6-K
EX-99.2
blhqmxs1x40arxtvs
2 Nov 20
Securities Purchase Agreement
8:45am
424B3
e0qgxo sr9
30 Sep 20
Prospectus supplement
5:14pm
F-1/A
wryi5vesbo6
14 Sep 20
Registration statement (foreign) (amended)
4:56pm